Digoxin immune fab (DigiFab)

🧮 Dose calculator

Digoxin toxicity · Regimen source: FDA DigiFab · 2.1FDA DigiFab · 2.2

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA DigiFab · 8.1

  “Risk Summary Animal reproduction studies have not been conducted with DIGIFAB.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA DigiFab · 8.2

  “Because many drugs are excreted in human milk, caution should be exercised when DIGIFAB is administered to a nursing woman.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA DigiFab · 8.4

  “Safety data in pediatric population is limited.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA DigiFab · 8.5

  “There is no evidence that the efficacy of DIGIFAB would be altered due to advanced age alone; however, elderly patients have a higher chance of having impaired renal function and therefore should be monitored more closely for recurrent toxicity (See 5.3 Use of DIGIFAB in renal failure).”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.